---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-009222"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2023-03-28T23:59:59+00:00"
generated_at: "2026-06-17T12:32:44.657348+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience closes $3M offering with warrants exercisable at $0.63

## Summary
- Gross proceeds of ~$3.0M from sale of 3,680,000 shares (or pre-funded warrants) and 5,520,000 warrants.
- Warrants exercisable immediately at $0.63/share, expire in eight years.
- Net proceeds to repay up to $500K convertible debentures (at 105%) and fund acquisition down payment for Wisconsin Facility Institute.
- Placement agent Maxim Group LLC received 5.0% fee and warrants for 147,200 shares at $0.8965.
- Officers and directors subject to 180-day lock-up on equity transactions.

## SEC filing metadata
- accession: 0001493152-23-009222
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2023-03-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.04, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315223009222/0001493152-23-009222-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315223009222/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-009222
- JSON: https://secwatch.observer/filing/0001493152-23-009222.json
- Plain text: https://secwatch.observer/filing/0001493152-23-009222.txt

## Key facts
- Material Agreements
  INVO Fertility, Inc. entered into Placement Agency Agreement with Maxim Group LLC (effective 2023-03-23).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Maxim Group LLC
  - Effective: 2023-03-23
  source text: Also in connection with the offering, on March 23, 2023, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315223009222/0001493152-23-009222-index.htm
- Material Agreements
  INVO Fertility, Inc. entered into Purchase Agreement with certain institutional investors (effective 2023-03-23).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain institutional investors
  - Effective: 2023-03-23
  source text: On March 23, 2023, INVO Bioscience, Inc., a Nevada corporation (the “Company”), entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315223009222/0001493152-23-009222-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.